Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us

Session 126   Poster Abstracts
Antiretroviral Therapy in Pregnant Women
Monday, 1:30 - 3:30 pm
Poster Hall
920Tolerance, Safety, and Efficacy of Highly Active Antiretroviral Therapy in HIV-infected Pregnant Women in the Netherlands from January 1997 to June 2003
M van der Ende*1, C Tempelmans1, S Timmermans1, J Dieleman1, M Godfried2, J Nellen2, K Boer2, H Sprenger3, M Schneider4, R Kauffmann5, J Jutman6, and R Vriesendorp7
1Erasmus Med. Ctr., Rotterdam, The Netherlands; 2Academic Med. Ctr., Amsterdam, The Netherlands; 3AZG, Groningen, The Netherlands; 4UMCU, Utrecht, The Netherlands; 5Leyenburg Hosp., The Hague, The Netherlands; 6St. Elisabeth Ziekenhuis, Tilburg, The Netherlands; and 7MC Haaglanden, The Hague, The Netherlands
921
Increased Risk of Pre-eclampsia and Fetal Death in HIV-infected Pregnant Women Receiving Highly Active Antiretroviral Therapy
O Coll*, A Suy, E Martinez, M Lonca, E de Lazzari, S Pisa, M Larrouse, A Milinkovic, S Hernandez, J Mallolas, J L Blanco, J M Miro, V Cararach, J A Vanrell, and J M Gatell
Corp. Sanitaria Clin., Barcelona, Spain
922Virologic and Clinical Outcomes in HIV-infected Pregnant Women: Directly Observed Therapy Can Overcome Barriers to Care.
A Bryant*, J Collingham, M Till, and P Garcia
Northwestern Univ., Feinberg Sch. of Med., Chicago, IL, USA
923Nevirapine Tolerability in HIV-infected Women in Pregnancy
F Kramer, A Stek*, W B Du, and A Kovacs
Univ. of Southern California, Los Angeles, USA